Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.

The aim of the present study was to characterize the volatile metabolites produced by genotypically diverse strains of the Stenotrophomonas genus in order to evaluate their potential as biomarkers of lung infection by non-invasive breath analysis. Volatile organic compounds (VOCs) emitted from 15 clinical and five environmental strains belonging to different genogroups of Stenotrophomonas maltophilia (n = 18) and Stenotrophomonas rhizophila (n = 2) cultured in Mueller-Hinton Broth (MHB) liquid media were analysed by gas chromatography mass spectrometry (GC–MS) and selected ion flow tube mass spectrometry (SIFT–MS). Several VOCs were detected in high concentration, including ammonia, propanol, dimethyl disulphide propanol and dimethyl disulphide. The GC–MS measurements showed that all 15 clinical strains produced similar headspace VOCs compositions, and SIFT–MS quantification showed that the rates of production of the VOCs by the genotypically distinct strains were very similar. All in vitro cultures of both the Stenotrophomonas species were characterised by efficient production of two isomers of methyl butanol, which can be described by known biochemical pathways and which is absent in other pathogens, including Pseudomonas aeruginosa. These in-vitro data indicate that methyl butanol isomers may be exhaled breath biomarkers of S. maltophilia lung infection in patients with cystic fibrosis.

[1]  David Smith,et al.  Quantification by SIFT-MS of volatile compounds emitted by Aspergillus fumigatus cultures and in co-culture with Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pneumoniae , 2014 .

[2]  David Smith,et al.  Quantification by SIFT-MS of volatile compounds emitted by in vitro cultures of S. aureus, S. pneumoniae and H. influenzae isolated from patients with respiratory diseases , 2014 .

[3]  P. Sterk,et al.  Volatile metabolites of pathogens – a Systematic review Plos Pathogens 2013 , 2014 .

[4]  P. Španěl,et al.  Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection , 2013, Journal of breath research.

[5]  P. Smith,et al.  Advances in On-line Absolute Trace Gas Analysis by SIFT-MS , 2013 .

[6]  P. Španěl,et al.  Real time monitoring of population dynamics in concurrent bacterial growth using SIFT-MS quantification of volatile metabolites. , 2013, The Analyst.

[7]  J. Greenman,et al.  Review: In vitro biofilm models for studying oral malodour , 2013 .

[8]  Peter J. Sterk,et al.  Volatile Metabolites of Pathogens: A Systematic Review , 2013, PLoS pathogens.

[9]  V. Shestivska,et al.  Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa , 2012, Journal of applied microbiology.

[10]  Heather D. Bean,et al.  Bacterial volatile discovery using solid phase microextraction and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  Anton Amann,et al.  Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosa , 2012, BMC Microbiology.

[12]  V. Waters.  New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. , 2012, Current pharmaceutical design.

[13]  P. Dřevínek,et al.  DNA profiling of Stenotrophomonas maltophilia by PCR targeted to its species‐specific repetitive palindromic sequences , 2012, Letters in applied microbiology.

[14]  J. Brooke.  Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen , 2012, Clinical Microbiology Reviews.

[15]  Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain , 2012, BMC Microbiology.

[16]  J. Winter,et al.  Genotyping of Environmental and Clinical Stenotrophomonas maltophilia Isolates and their Pathogenic Potential , 2011, PloS one.

[17]  V. Shestivska,et al.  Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. , 2011, Rapid communications in mass spectrometry : RCM.

[18]  B. Ross.  Changes in oral trace gas concentrations following orthognathic surgery and intermaxillary fixation: a case study using selected ion flow tube mass spectrometry , 2011, International Journal of Oral Science.

[19]  P. Corris,et al.  Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis , 2011, Letters in applied microbiology.

[20]  David Smith,et al.  Progress in SIFT-MS: breath analysis and other applications. , 2011, Mass spectrometry reviews.

[21]  T. Maier,et al.  Delineation of Stenotrophomonas spp. by multi-locus sequence analysis and MALDI-TOF mass spectrometry. , 2011, Systematic and applied microbiology.

[22]  Yang‐Chun Yong,et al.  Recent advances in biodegradation in China: New microorganisms and pathways, biodegradation engineering, and bioenergy from pollutant biodegradation , 2010 .

[23]  James C. Liao,et al.  3-Methyl-1-butanol production in Escherichia coli: random mutagenesis and two-phase fermentation , 2010, Applied Microbiology and Biotechnology.

[24]  David Smith,et al.  Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS. , 2009, The Analyst.

[25]  J. M. Dow,et al.  The versatility and adaptation of bacteria from the genus Stenotrophomonas , 2009, Nature Reviews Microbiology.

[26]  D. Jonas,et al.  A Stenotrophomonas maltophilia Multilocus Sequence Typing Scheme for Inferring Population Structure , 2009, Journal of bacteriology.

[27]  David Smith,et al.  Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis , 2009, Pediatric pulmonology.

[28]  Tomas Mikoviny,et al.  Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro , 2008, Cancer Cell International.

[29]  J. Liao,et al.  Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways. , 2008, Metabolic engineering.

[30]  J. Liao,et al.  Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels , 2008, Nature.

[31]  David R Murdoch,et al.  Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). , 2006, Journal of microbiological methods.

[32]  P. Španěl,et al.  Bronchoalveolar lavage examined by solid phase microextraction, gas chromatography--mass spectrometry and selected ion flow tube mass spectrometry. , 2006, Journal of microbiological methods.

[33]  David Smith,et al.  A general method for the calculation of absolute trace gas concentrations in air and breath from selected ion flow tube mass spectrometry data , 2006 .

[34]  L. Eberl,et al.  The rhizosphere as a reservoir for opportunistic human pathogenic bacteria. , 2005, Environmental microbiology.

[35]  David Smith,et al.  Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. , 2005, Mass spectrometry reviews.

[36]  P. Španěl,et al.  A convenient method for calculation of ionic diffusion coefficients for accurate selected ion flow tube mass spectrometry, SIFT-MS , 2005 .

[37]  M. Hagemann,et al.  Stenotrophomonas rhizophila sp. nov., a novel plant-associated bacterium with antifungal properties. , 2002, International journal of systematic and evolutionary microbiology.

[38]  G. Berg,et al.  Comparison of Antifungal Activities and 16S Ribosomal DNA Sequences of Clinical and Environmental Isolates ofStenotrophomonas maltophilia , 2001, Journal of Clinical Microbiology.

[39]  D. Pittet,et al.  Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. , 2000, Scandinavian journal of infectious diseases.

[40]  K. Smalla,et al.  Genotypic and Phenotypic Relationships between Clinical and Environmental Isolates of Stenotrophomonas maltophilia , 1999, Journal of Clinical Microbiology.

[41]  J. Swings,et al.  Genomic diversity of the genus Stenotrophomonas. , 1999, International journal of systematic bacteriology.

[42]  K. Kerr,et al.  Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia , 1998, Clinical Microbiology Reviews.

[43]  J. G. Morris,et al.  Anaerobic bacterial reductions of aldehydes and ketones: a rapid screening procedure , 1993 .

[44]  G. Pacioni.  Effects of Tuber metabolites on the rhizospheric environment , 1991 .

[45]  H. Drake,et al.  Biotransformations of aromatic aldehydes by acetogenic bacteria. , 1990, FEMS microbiology letters.

[46]  D. Sands,et al.  Relationship between bacterial seed inoculum density and rhizosphere colonization of spring wheat , 1989 .

[47]  J. Leyden,et al.  Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry , 1980, Journal of clinical microbiology.